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RNA viruses are a major health problem of humans and domesticated animals 
globally. The RNA virus-host cell co-evolution has led to both the pathogens 
and the hosts adapting to control each other. Yet, the mechanisms by which 
host cells resist RNA viral infection is incompletely understood. The ubiquitin 
ligases are a family of human proteins involved in both the regulation of 
cellular signaling and functioning of proteins. Given their importance in cell 
physiology, it is likely that ubiquitin ligases may have a prominent role in 
either supporting (proviral factor) or restricting (restriction factor) viral 
infection. However, till date, no study has evaluated the role of ubiquitin 
ligases in the infection of RNA viruses at a genome scale, and thus there is a 
paucity of information on their role in host-virus interactions.  
 
EV71 is an RNA virus causing major human health problems such as hand-
foot-and-mouth disease as well as neurological complications. Although 
ubiquitination is critical for regulating key cellular processes and immune 
responses, the “global role of ubiquitination processes” in ENTEROVIRUS 71 
infection of human host cells is not determined till date. To address this, we 
systematically over expressed >90% of the ubuquitination-mediating genes 
(E3 Ubiquitin ligases [UBL] and their adaptors) encoded in human-genome in 
293T cells, infected the cells with ENTEROVIRUS 71 for 24h, and 
determined viral load using immune-fluorescence staining coupled with high-
content microscopy and statistical data analysis. We identified 54 pro-viral 
and 65 antiviral UBLs. Counter screen of these hit UBLs with dengue virus 
revealed both pan-viral and virus-specific effect of UBLS on infection. 
Subsequent mechanistic studies indicated that a subset of 10 antiviral UBLs 
potentially inhibited EV71 by degrading its receptors SCARB2. Our study 
thus identified several novel UBLs impacting on EV71 infection, revealing 
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RNA viruses are a major threat to human health. Positive stranded RNA viruses 
cover more than one third of all virus genera and infect a wide range of hosts - 
plants, animals and humans. Given their importance, it is of great interest to study 
how RNA viruses interact with the host cells, and particularly how host cells 
resist RNA viral infection. 
1.1 Enterovirus71 
Enterovirus 71 (EV71), is an emerging positive single stranded RNA virus that 
belongs to the enterovirus species A of the genus enterovirus within the family 
Picornavidae1. The picornaviridae family includes Rhinovirus species (the 
common cold), Hepatovirus species (human hepatitis A virus), Parechovirus 
species (human parechovirus 1 and 2), and two animal important genera, 
cardiovirus species (such as encephalomyocaditis virus) and Apthovirus species 
which causes foot and mouth disease in animals. EV71 is genetically close to 
other human enterovirus species A virus; Coxsackievirus A16 (CA16) which also 
causes hand foot and mouth disease. EV71 has only one single serotype that can 
be phylogenetically classified into four genotypes; A, B, C and D2. The genotypes 
B and C comprises of five sub genotypes; B1-B5, C1-C5 respectively.  
1.2 Enterovirus 71 - Geographical distribution 
 
Enterovirus 71 was first isolated in 1969 in California, United States of America 
and later recognized as the causative agent of hand-foot-mouth disease in humans 
in Japan in 19733,4. Several countries including Taiwan, Japan, Malaysia, 
Singapore and Vietnam experienced cyclical epidemics occurring every 2 or 3 
years in the 2000’s. For the past 10 years, EV71 has been isolated in Europe 
(France, Denmark, Spain and Portugal) and American countries (Brazil, Canada, 
and the United States of America). Comprehensive phylogenetic analysis of 
evolutionary aspects of EV71 using the VP1 sequence indicated that C4, C1, C2 




1.3 Enterovirus 71 - Genome organization and virus structure 
EV 71 is non-enveloped, single stranded RNA with a genomic RNA of 
approximately7500 nucleotides long and diameter of 30nm. The genome encodes 
4 structural proteins, icosahedral capsid of 60 identical sub-units each of which is 
made up of one copy of VP1, VP2 and VP3 which are external with VP4 being 
completely internalized and is not exposed to the host antibody response. All the 
structural proteins are encoded by the P1 region of the genome. The RNA has a 
small virus encoded protein VPg which is covalently attached to its 5’ end and 






Figure 1 Regions with reported EV71 outbreaks 
The map shows different areas with reported cases of EV71 as an emerging infectious disease, 
with a range from Canada, United states, Brazil, Australia, Asia: China, South Korea, 
Malaysia, Cambodia, Taiwan, Japan, Europe: Spain, France, Norway, Netherlands, Sweden, 










The single open reading frame (ORF) is flanked by highly structured 5’UTR and 3’UTR 
followed by a poly (A) tail. The 5’ end of the viral genome is covalently bound to the 
viral VPg protein. The ORF is divided into three regions. P1 encodes four structural 
proteins, VP1 to -4. P2 and P3 encode seven nonstructural proteins, 2A to 2C and 3A to 
























Figure 2 Structure of the EV71 genome. 
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The information on the EV71 viral proteins; both structural and non-structural are based 
from inferred functions from sequence similarity and the Gene Ontology. The data was 
accessed from uniprot. 
 
1.4 EV71 replication 
Like many other enteroviruses, the replication of EV71 is similar to that of 
Polioviruses. The binding of the EV71 to the receptor leads to a series of changes 
in the viral capsid (not yet defined for EV71) and pores formed on the cell 
membrane through which the viral RNA is released into the host cell cytoplasm. 
After infection of the host cells, the genome is translated in a cap-independent 
manner into a single poly protein which is subsequently processed by virus 
encoded proteases; 2Apro and 3Cpro into the 11 structural capsid proteins and non-
structural proteins. The replication of the virus by the RNA dependent RNA 
polymerase occurs in the vesicle membrane structure. The polymerase is 
estimated to miss-incorporate one or two bases in every genome copying event, 
which explains why the virus mutates and evolves rapidly. The viral 2A protease 
shuts off the host cellular protein synthesis while the viral protein synthesis is 
unaffected and the infectious viral particles are formed after package of the 
progeny viral RNA into viral capsid in the cytoplasm of infected cells. The mature 
viral infectious particles are released when the infected cells are lysed. 
1.5 EV71 – Host Cell interactions 
1.5.1 Cellular receptors for EV71 Virus: 
The tropism of EV71 for its target cells depends on specific cell surface 
molecules (receptors) that mediate viral binding and entry into the cell.  Virus 
receptors are the primary determinants of host range and tissue tropism. Although 
several receptors have been identified for EV71, the human scavenger receptor 
class B member 2 and human P-selectin glycoprotein ligand-1 found on white 
blood cells are generally viewed as the major EV71 receptors7,8. Other receptors 





Human scavenger receptor class B member 2 (SCARB2 also known as lysosomal 
integral membrane protein II) was shown to be a receptor for EV717. The EV71 
was shown to bind to soluble SCARB2 or cells expressing SCARB2  and the 
normal binding inhibited by an antibody to SCARB2. The expression of the 
human SCARB2 enables normally unsusceptible cell lines to support EV71 
propagation and develop cytopathic. Since the identification of this receptor, there 
has been a better  understanding of the pathogenicity of EV71. Infection 
efficiency is higher in SCARB2 than the PSGL1 in mouse L cells and this was 
attributed to the ability of these cells to viral binding, viral internalization and 
viral uncoating8. The  human SCARB2 has been known as a uncoating receptor 
thus contributing to the understanding of the early steps of EV71 infection. 
SCARB2 has 2 transmembrane domains and is known receptor for β-
glucocerebrosidase (β-GC) transport from the endoplasmic reticulum to the 
lysosome and plays an important role in the maintenance of lysosomes9. Mouse 
cells have been shown to be susceptible to all strains of EV71 when they express 
human SCARB27. EV71 binds to the luminal domain of SCARB2 at amino acid 
142 to 204 and amino acids 144 to 15510. SCARB2 is widely expressed on 
various types of cells including the neurons which are involved in the EV71 
infection of the brain. The structural changes in SCARB2 in acidic and neutral 
conditions have shown that SCARB2 undergoes conformational changes which 
open up the lipid- transfer tunnel to mediate expulsion of the hydrophobic pocket 
factor from the virion, a pre-requisite for un-coating11.  
1.5.1.2 SELPLG1 
Human P-selectin glycoprotein ligand-1 (PSGL1; Cd162), a sialomucin 
membrane protein expressed on leukocytes, plays major roles in inflammation, 
and tethering/rolling of leukocytes on vascular endothelial. PSGL1 was shown to 
be a functional receptor for EV71 entry into blood cells12. PSGL-1 is expressed as 
a homodimer of disulfide-linked subunits and can bind to 3 different selectins; 
P,E and L. PSGL1 is expressed on myeloid cells, stimulated T lymphocytes and 
has been known to play critical role in tethering and rolling of leukocytes for 
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recruitment of these cells from blood vessels into inflamed tissues13. Several 
strains of EV71 bind to PSGL1 and this requires tyrosine sulfations at the N-
terminal region of the PSGL18. PSGL1 has high binding capabilities of the EV71 
virus compared to human SCARB2 but with low infection efficiency and this has 
been attributed to its inability to induce viral uncoating8. 
The N-terminal region of PSGL-1 binds specifically to EV71, and it has been 
shown that a post-translational modification, tyrosine sulfation and not O-
glycosylation in the N-terminal region of PSGL-1 may facilitate virus entry and 
replication in leukocytes14. Conserved lysine residues on the virus surface are 
responsible for interaction with sulfated tyrosine residues at the PSGL-1 N-
terminus and VP1-145 acts a switch, controlling PSGL-1 binding by modulating 
exposure of VP1-244K10. 
1.5.2 Host factors involved in EV71 infection - translation 
Host immune responses are essential factors in determining EV71 infection 
outcomes. EV71 5’ untranslated region contains type 1 internal ribosomal entry 
site (IRES) which is approximately 500 nucleotides and has poor efficiency in 
initiating viral translation in absence of certain cellular proteins15. Viral 
translation through IRES dependent pathway requires several trans-acting host 
factors; IRES trans-acting factors (ITAFs) which play important roles such as 
binding to viral RNA across multiple domains, stabilizing the IRES. Several host 
factors that interact with EV71 IRES have been identified some of which had 
been observed to interact with 5’UTR of other picornaviruses to enhance virus 
replication15. Some of these ITAFs have been shown to interact with EV71 IRES, 
and have either a negative regulatory effects or positive. The far upstream element 
binding protein1 and 2 (FBP1 and FBP2), and heterogeneous nuclear 
ribonucleoprotein (hnRNP) A1 have been shown to be novel ITAFs for EV71. 
FBP1, FBP2 and hnRNP relocates from nucleus to the cytosol during EV71 
infection and they bind to the EV71 5’UTR where they play positive roles in 
EV71 IRES activity. FBP2 is an IRES trans-acting factor that negatively regulates 
EV71 translation. The virus induced proteasome, autophagy, and caspase activity 
co-contribute to EV71 induced cleavage of FBP216. The cleaved products of 
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FBP2 alter the activity of FBP2 from negative regulator to positive regulator of 
IRES activity15.  Figure 3 describes the mechanisms how ITAFs regulate EV71 
IRES. 
 
1.5.2 Host factors involved in EV71 infection - MicroRNAs 
Viruses have co-evolved with host cells strategies to establish debilitating 
infections with mircoRNA (miRNA) which are small single stranded RNA 
species of about 20-24 bases being one of such regulators18,19. Both viruses and 
hosts have been shown to encode the miRNAs. Viruses depend on host cellular 
machinery for propagation and survival making them susceptible to cellular 
molecules such as small RNA mediated interference and at the same time giving 
them an opportunity to fight and or modulate host to meet its own needs18. 
miRNAs have been shown to play an important role in post-transcriptional 
Figure 3 Role of host proteins as ITAFs to regulate EV71 translation. 
An overview of the host proteins involved in the regulation of EV71 translation 
machinery. Upon EV71 infection, the FBP1, FBP2, and hnRNP A1 relocates to the 
cytosol where they bind to the 5’ UTR of EV71 playing a positive role in EV71 IRES 
activity. The viral induced proteasome, autophagy, caspace activity induces cleavage of 




regulation of gene expression, regulating different cellular cell functions such as 
cell proliferation, differentiation, homeostasis, immune activation and apoptosis 
thus contributing to the repertoire of host-pathogen interactions during infection  
through modulating and directing host and viral gene expression20,19. 
EV71 has been shown to utilize the host miRNAs to mediate host immune 
systems for survival during infection. Using double stranded RNA binding 
protein; DiGeorge Syndrome Critical Region (DGCR8) Lui et al showed that 
when DGCR8 an essential cofactor for miRNA biogenesis is knocked down, there 
was reduced EV71 replication21. These results suggest that there is remodeling of 
host miRNAs during EV71 infection playing an important role in antiviral 
response and opens a further need for more research on how best miRNAs can be 
used to develop miRNA inhibitors against EV71. These studies points out the 
importance of understanding the host-pathogen interaction for better management 
of viral diseases. 
 
Figure 4 life cycle of a human enterovirus 
VP0, VP1 and VP3 forms a single protomer, five of which forms a pentamer.12 pentamers 
self-associate into empty capsid 1A, with the genome inserted 1B. Second pathway involves 
formation of a proviron from 12 pentamers (2). Autocatalytic cleavage of VP0 to VP2 and VP4 
leads to the viral binding to the cellular receptor resulting to expulsion of VP4 the N-terminus 




1.5.3 EV71 infection and innate immunity 
1.5.3.1 Innate Immune antiviral pathways 
Innate immune system had long been regarded as non-specific system, with roles 
being to engulf and destroy pathogens triggering pro-inflammatory responses and 
to help present antigens to adaptive immune response. Recent studies have shown 
that the innate immune system has a great degree of specificity enabling it to 
discriminate efficiently between self and foreign entities. Host innate immune 
responses are usually associated with the activation of the pattern recognition 
receptors (PRRs) pathways including production of interferons. PRRs include the 
Toll-like receptors (TLRs), NOD-like receptors (NLRs), DExD/H box helicases 
such as retinoic acid inducible gene I (RIG-I) -like receptors (RLRs)  and 
melanoma differentiation-associated gene 5 (MDA5)22. The PRRs are encoded in 
the germline and are expressed constitutively by both immune and non-immune 
cells. The pattern recognition receptors detect the pathogen associated molecular 
patterns (PAMPs) resulting to robust and highly defined innate immune response, 
and at the same time helping to prime subsequent protective adaptive immune 
responses to the invading pathogens. 
The TLRs are expressed by various cell types and most notably TLR3 (detects 
dsRNA), TLR7 and TLR8 (detects ssRNA) receptors are able to detect 
intracellular RNA. The TLRs contain a ligand sensing leucine-rich repeats on the 
extracellular domain and a Toll/IL-1R homology (TIR) on the cytoplasmic 
signaling domain. Both MDA5 and RIG-I are homogenous interferon inducible 
activated by sensing RNA species. TYPE 1 IFN production is activated by 
pathogen associated molecular patterns through host pathogen recognition 
receptors. In response to double stranded RNA, toll-like receptor 3 (TLR3) 
recruits the adaptor TRIF and TANK-binding kinase 1 (TBK1), which 
phosphorylate interferon regulatory factor 3 (IRF3)/ IRF7.Cytosolic receptors; 
retinoic acid inducible gene-I (RIG-I) and melanoma differentiation-associated 
gene (MDA5) recruits adaptor IPS-1/MAVS and TBK-1 to activate IRF3 or IRF7. 
The produced interferon can bind to the same cell or neighboring cells exerting 
antivirus effects. Upon recognition of single stranded RNA, TLR7, TLR8 relay 
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signal to adaptors MyD88 and TRAF6 leading to activation of the kinase IRAK-1 
to phosphorylate the transcription factor IRF7 which translocates to the nucleus 
and induces TYPE 1 IFN expression.  
1.5.3.2 Innate immune system – Ev71 interactions 
The pathogenecity of EV71 is not well understood but innate immune evasion 
seems to be a major factor. The viral proteases of picornaviruses such as 
coxsackievirus B 3C attenuates host type 1 interferon induction by cleavage of 
MAVS and TRIF23. The production of inteferonβ upon EV71 infection might be 
cell specific but no IFNβ production has been reported in clinical observations. 
EV71 3C protease can cleave the adaptor protein TRIF (Toll/interleukin-1 
receptor domain containing adaptor inducing interferon-β) in response to TLR3 
activation24. EV71 protease can also associate with RIG-I (retinoic acid-inducible 
gene I) impairing recruitment of interferon-β-promoter stimulator 1 (IPS-1) and 
IRF3 activation.  
EV71 2A protease (2Apro) inhibits antiviral type 1 IFN responses by targeting the 
mitochondrial anti-viral signaling (MAVS) protein adaptor molecule activated 
upon retinoic acid induced gene I (RIG-I) and melanoma differentiation 
associated gene (MDA5) viral signaling upstream of type 1 IFN production25.  
EV71 2A protease have also been associated with reduction of IFN receptor I 
(IFNAR I) expression that inhibits type 1 IFN signaling26. MAVS is cleaved, 
released from mitochondria during EV71 infection which at the same time 
induces morphological and functional changes to the mitochondria25. EV71 3C 
protease inhibits RIG-I, MAVS interaction and is able to cleave TIR domain 
containing adaptor inducing IFN-β (TRIF)  key TLR3 adaptor molecule inhibiting 
type 1 IFN production24,27. 
1.5.4 Adaptive immune response to EV71 infection 
Inflammation mediators plays major role in the process of EV71 infections with 
both central nervous system and systemic inflammatory responses resulting to 
EV71 pulmonary edema. Central nervous system, systemic inflammatory 
responses plays an important role in EV71 pathogenesis in pulmonary edema 
cases. EV71 induced brain stem-encephalitis complicated by pulmonary edema 
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have revealed association with IL-6, TNF-alpha, IL-10, IL-13, and IFN-
gamma28,29. In neonate mouse model infected with EV71, IL-6 was associated 
with severe tissue damage and death30.Significantly high levels of TH17 cells in 
blood from EV71 infected children has been reported31, while increased levels of 
IFN-gamma induced protein-10 in EV71 cases with pulmonary edema32. There 
have been suggestions that TLR2, TLR7, and TLR8 play a partial role in the 
production of cytokines in EV71-infected monocyte derived macrophages33. 
Proteomic studies have shown down regulation of complement C3, inter-alpha 
(globulin) inhibitor H2, serum albumin, plasminogen and retinol-binding protein 
4, with increased peroxiredoxin-2 in extreme cases of HFMD34. EV71 entry into 
dendritic cells, a professional antigen presenting cells priming T cells, was 
mediated by DC-SIGN leading to increased viability, activation and release of 
cytokines, IL-6, IL-12 and TNF-alpha in the infected dendritic cells35. 
1.6 Ubiquitin and Ubiquitination 
The human immune system is bestowed with a complex network of cells, 
receptors and signaling pathways each playing a role in the fight of many 
invading pathogens, while at the same time being able to distinguish self from non 
self.  This specificity is not only achieved by the variety of the immune cells but 
also through the post-translational modification of proteins (PTMs) involved in 
the immune system. With over 200 post-translational modifications reported, 
phosphorylation, and Ubiquitination are the most studied and reported36. There 
has been reported growing evidence of the Ubiquitination on stimulation, 
maintenance, and termination of the immune systems response to many stimuli. 
1.6.1 The ubiquitination process 
Ubiquitination is a post-translational modification, involving the 8kDa Ubiquitin 
protein attachment to one or more of the lysine residues of proteins. This 
Ubiquitination is a three step sequence of events; activation, conjugation and 
ligation involving 3 enzymes E1, E2 and E3. The first step is ATP dependent 
initiated by ubiquitin activating enzyme (E1), resulting in the formation of a labile 
thioester bond between ubiquitin protein (Ub) and the E137. The second step 
involves the transfer of ubiquitin from E1 to the active site of cystein of ubiquitin 
13 
 
-conjugating enzyme, E238. The final step is executed by E3ubiquitin ligase 
enzyme catalyzing the ligation of the carboxy-terminal residue of ubiquitin to a 
lysine residue on the target protein resulting to the formation of ubiquitin 
polymers in which the internal lysine residues of one of the ubiquitin is attached 






















The human genome encodes only 2 E1 activating enzymes, approximately 38 E2 
conjugating enzymes and more than 600 E3 ligating enzymes thus explaining the 
diversity, complexity and specificity of the ubiquitination process. The E2 
conjugating enzymes are capable of mediating self linkage specificity either on 
their own or through help of a cofactor or a respective substrate40,41. The substrate 
specificity is ensured by the E3 ligases which possess linkage specificity 
independent of the E2 enzymes42. 
Figure 5 the pathway involved in the Ubiquitination process 
E1 ubiquitin activating enzyme forms a thioester linkage with Ub in presence of 
ATP, leading to the transfer of Ub to the active site of E2 ubiquitin conjugating 
enzyme with the last step executed by E3-ubiquitin ligase resulting in formation 




1.6.2 E3 ligase subfamilies 
The ligases are divided into three families based on their respective domain 
structure: HECT, RING and RBR and the domain organization determines the 
mechanism of ubiquitination process. The HECT domains are identified based on 
the similarity sequence to the C-terminal catalytic domain of E3 ligase 
E6associated protein (E6AP) and are always located on the C-terminus of an 
E343.The Ubiquitin is transferred from E2 to an active site cystein of the E3 
before being transferred to the substrate in HECT E3 ligases44. 
The really interesting new gene (RING) domains are characterized by the 
consensus sequence of cysteines and histidines that bind to two zinc ions42 and 
can occur anywhere in an E3. The E3s with RING domain structure are able to 
bring the Ubiquitin bound to E2 and substrate into close proximity for direct 
transfer of the E2s to the substrate.  
RING-between-RING Es has three domains close to each other; the classical 
RING domain: RING1, an in-between RING (IBR) domain and a second RING 
domain: RING2 which are only found in exclusively in RBRE3s45. The RBR 
domain has features similar to the HECT and RING E3s and it first binds to E2s 
complexed with ubiquitin through the RING domain with an additional step for 
subsequent ubuquitination involving an active site cystein in the RING2 
catalyzing transfer of ubiquitin from E3 to the substrate (thus acting in a HECT 
like manner)46.   
1.6.3 Regulation of Ubiquitination process 
The termination of an immune response is vital as its priming and propagation. 
This point out need to terminate ubiqutination process which is achieved by 
removal of ubiquitin chains from signaling complexes by the de-ubiquitinating 
enzymes (DUBs).DUBs, proteases mediate removal of ubiquitin chains by 
hydrolyzing the isopeptide bond between the c-terminal glycine of the distal 
molecule and lysine residue in either proximal ubiquitin or the protein substrate47. 
Human genome encodes about 80 known DUBs, which have been grouped into 
five distinct families including; ubiquitin-specific proteases (USPs), ubiquitin C-
terminal hydrolase (UCHs), ovarian tumor domain proteases (OTUs), Machado-
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Joseph Disease (MJD) protein family which are all cystein proteases, 
JABI/MPN/MOV3 metallo-enzymes (JAMM) are metallo-proteases48. There is 
little knowledge on the specificity and mode of regulation of DUBs due to 
challenges in isolating DUB containing protein complexes49. Using engineered 
Di-Ub mimicking all the 8 different poly-ub linkages, McGouran., et al 2013, 
profiled the selectivity of DUBs for recognizing Di-Ub moieties in cellular 
extracts50. For example; K11 linkages are cleaved by Cezan 1, TRABID shown to 
cleave K-29 and K-33 linkages, OTUB1 cleaves K48-linkages, CYLD cleaves 
K63 and M1 linkages51. USP13, USP25,USP40 showed affinity for M1 linkages, 
USP15, USP16, USP47, USP24 showed affinity for k27 linkages, and USP5 
showing affinity for K11 linkages50. A20 was shown to be a negative regulator of 
NF-kB by cleaving K63 linkages on NF-kB signaling molecules such as RIP152.  
OTULIN (FAM 105B) antagonizes linear ubiquitin (Ub) chain assembly complex 
(LUBAC) by binding the conserved PUB-interacting motif (PIM) to the PUB 
domain of the LUBACcomponentHOIL-1L interacting protein(HOIP) 
hydrolyzing Met1-linked polyubiquitination53,54.However, how a particular DUB 
recognizes a particular linkages type and how cleavage by DUB regulates specific 
signaling events needs to be further studied55. 
The DUBs have also been linked to regulation of the innate immune system 
signaling pathways. Ubiquitin specific protease (USP) - 25 plays an important 
role in the shutting off TLR4 mediated induction of  MAPK signaling by 
restricting production of pro-inflammatory cytokines while at the same time 
promoting interferon production through stabilization of TRAF3 in LPS-
stimulated dendritic cells, macrophages, and MEFs56. With USP7 stabilizing NF- 
kappa B at target gene promoters by deubiquitinating it thus avoiding its 
proteasomal degradation, CYLD interacting and deubiquitinating RIG-I inhibiting 
its signaling, and OTULIN negatively regulating NOD2-mediated signaling by 
restricting accumulation of linear ubiquitin chains on RIP2 and LUBAC, among 
many other functions, points out the importance of DUBs in regulation of innate 
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signaling pathways and major role it plays in signaling and body defense 
mechanisms 57,58 .  
1.6.4 Role of Ubiquitination in RNA Viral infection – an Expanding Field 
Given the wide spread role of Ubiquitination system in cell physiology, it is 
predictable that genes that are part of the Ubiquitination system will have multiple 
roles in virus-host interactions. They may serve both proviral and antiviral roles. 
During the infection process, both the virus and host cells are in constant struggle 
for supremacy. Many viruses have evolved ways to shut-off the host immune 
signaling pathways for efficient establishment of infection, for example Ebola 
virus blocks the interferon-mediated antiviral response leading to extremely rapid 
replication59. The immense pressure on the human immune system by a myriad of 
viruses has forced the host cells to evolve several restriction factors that protect 
them from the viral infections. Identification of these restriction factors not only 
enables one to understand how host cells limit infections, but also enables us to 
identify the vulnerability points of viral infection that could be targeted for 
therapeutics and vaccine development to control viruses. There has been growing 
evidence on the importance of ubiquitination in the initiation, maintenance, and 
termination of the immune system response to many different stimuli. In the 
literature there is growing information on the role of ubiquitin ligases in either 
enhancing of inhibiting viral infections. For example, TRIM41 inhibiting the 
Hepatitis B Virus transcription in human hepatocyte-derived cells60, TRIM79α 
degrades tick born encephalitis viral RNA polymerase61,TRIM5-alpha restricting 
retrovirus replication62, TRIM22 inhibiting transcription activity of hepatitis B 
virus core promoter and human immunodeficiency virus-1 LTR63,64 with TRIM 
28 reported to be critical in silencing of endogenous retroviruses in embryonic 
stem cells65. While these data shows the importance of ubiquitin ligase families in 
viral infection, much remains to be studied. Ubiquitination has been linked to 
various cellular processes ranging from protein degradation and receptor 
trafficking to innate immunity 66,67,68. Ubiquitination is also used by host antiviral 
effector molecules as part of innate defenses accelerating degradation of key viral 
proteins as a way of restricting viral replication69. There has been increasing 
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evidence of suggesting that viruses have evolved evasion strategies that use and or 
disable the ubiquitin dependent responses through expression of viral ubiquitin 
like molecules, ubiquitin Ligases and de-ubiquitinases70. Different viruses have 
evolved ways of using host processes of ubiquitination to regulate viral proteins 
for the benefit of their replication and establishment of a successful infection. 
1.6.5 UBLs in EV71 infection – Poorly Understood Niche Area 
 
Our understanding of the role of ubiquitination related processes in EV71 
infection is very minimal. Sumoylation of the EV71 3C protein at lysine 52 was 
reported to promote its ubiquitylation and degradation71. The viral proteases are 
required for successful virus multiplication, through cleavage of viral polyprotein 
precursors. The degradation of 3C may be a host mechanism to inhibit EV71 
infection. Apart from this study, there has been no report on the role of 
ubiquitination related processes during EV71 infection. 
1.7 Knowledge gap addressed in this study – role of UBls in EV71 infection 
 
EV71 is an emerging infectious disease with a potential threat to the global health, 
and there is no approved vaccine or antiviral drug available against EV71. There 
is thus a need for conducting additional studies to better understand the molecular 
aspects of the disease which will lead to development of EV71 inhibitors. It is 
believed that host factors play a role in the EV71 pathogenesis but there is little 
known about their identity or underlying mechanisms. Given the widespread role 
of UBLs in cell physiology, and also that the role of UBLs in EV71 infection was 
not systematically studied yet, this study aimed to understand host cell-EV71 
interactions in the context of UBLs.In order to investigate the role of the ubiquitin 
ligases encoded in the human genome in EV71 virus infection, we over-expressed 
562 out of 614 commercially available human ubiquitin ligases in human 
embryonic kidney 293T cells (HEK293T) and assessed their ability to modulate 




2.0 MATERIALS AND METHODS 
2.1 Reagents 
The following reagents were used for the experiments in this study: 
2.1.1 Antibodies 
The following antibodies were obtained from commercial sources and used in the 
indicated dilutions for the IFA and Western blot analyses; 
Primary antibodies: V-5 Mouse monoclonal antibody, 1:200, LIMP II mouse 
monoclonal antibody, 1:200, PSGL-1 Mouse monoclonal antibody, 1:2000 (all 
from Santa Cruz Biotechnology.inc) diluted in 5% dry milk in TBST. The 
secondary antibodies: Odyssey goat anti Mouse IRDye 680, Odyssey goat anti 
mouse IRDye 800 at 1:5000 dilutions. Alexa Fluor® 488 Goat Anti-Mouse IgG 
(H+L) Antibody, Alexa Fluor 680goatanti—mouseIgGfrom Invitrogen was used 
for IFA at 1:5000 dilutions in IFA blocking buffer. A summary of the antibodies 
used in this project are shown in the table 3. 
2.1.2 Buffers 
For Western blot the following buffers were used: Lysis buffer: 50mM Tris-
HCL, 150mM NaCl, 1% NP-40 and 0.1% SDS, this was then supplemented with 
1X Protease and Phosphatase inhibitor (Roche) just before lysis step. 1X SDS 
page running buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS.1X Transfer 
buffer: 25 mMTris, 192 mM glycine, 10% methanol.1X Tris Buffered Saline 
with Tween 20 (TBST): 50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.1% Tween 
20. IFA buffers included; Permeabilization Buffer: 0.1% TritonX100, 1xPBS; 
IFAblocking buffer: 4% fetal bovine serum (FBS) in 1X PBS; RIPA buffer: 
50mM Tris-HCl, 150mM NaCl, 1% IGEPAL (SIGMA- ALDRICH), 0.1% 













V-5 mouse monoclonal antibody IgG1 1:200 Santa-Cruz 
Biotechnology  
LIMP II mouse monoclonal IgG2b 1:200 Santa-Cruz 
Biotechnology 
4G2 mouse monoclonal antibody 1:10 ATCC 
ODYSSEY-IRDye 680RD goat anti-
mouse 
1:5000 LI-COR 
Anti-GAPDH antibody-Rabbit 1:20,000 SIGMA-
ALDRICH, Israel 
ODYSSEY-IRDye 800RD goat anti-
Rabbit 
1:5000 LI-COR 
mAb 53 1:10 72 
Alexa Fluor 680goatanti—mouseIgG 1:5000 Invitrogen 
2.1.3 Chemicals 
The following chemicals were used; 4% Paraformaldehyde(PFA) for fixing cells 
during IFA, Polyethylenimine (PEI) transfections reagent (Sigma-Aldrich, 
USA),4',6-diamidino-2-phenylindole (DAPI) was used for staining the cells in 
IFA. Tetramethylethylenediamine (TEMED)-Sigma-USA, ammonium persulfate 
(APS)-Sigma-Aldrich USA. 
2.2 Cells, plasmids, medium 
Human Embryonic Kidney (HEK) 293 cells from the American Type Cell 
Collection (ATCC Manassas USA) were maintained in DMEM (Invitrogen, 
Auckland) supplemented with heat inactivated 10% FBS (Invitrogen, South 
America), on 100mm tissue culture dishes (Coaster). The cells were incubated at 




DH5α bacterial cells were obtained from Invitrogen, California, and competent 
cells. Luria-Bertani (LB) broth and agar were purchased from Becton Dickinson, 
USA. QIAGEN Plasma Maxi Kits were from Qiagen, Singapore. 
The ubiquitin ligase genes were purchased from two sources: a subset of the 
UBLgenes, cloned into the pLX304-V5 tag lentiviral mammalian expression 
vector, was purchased from DNASU (Arizona State University); another set of 
UBL genes, cloned into the pFN21A-HaloTag mammalian expression vector was 
purchased from Promega Corporation. The plasmids were supplied as transformed 
glycerol stocks, and store in -80 freezer. The pLX304-V5 vector is a third 
generation lentiviral vector, and was handled in accordance with the regulations 
of the institutional biosafety regulatory organization.  
2.2.1 Plasmid isolation 
DH5α competent bacterial cells (Invitrogen, California) were transformed with 
the plasmids and incubated on ice for 30 minutes before heat shock treatment at 
420C and cold shock treatment at 00C for 2 minutes respectively. 500µl of LB 
broth (Becton Dickinson, USA) was added, and the cells were incubated at 37 0C 
with shaking for 1 hour. To select for transformants, 100µl of the transformed 
cells were plated overnight on separate Luria-Bertani (LB) agar (Becton 
Dickinson, USA) plates with either 50µg/ml of Ampicillin or 25µg/ml of 
Kanamycin depending on the plasmid antibiotic marker. A single colony was 
picked from the overnight freshly streaked plate and inoculated in 6mL of LB 
broth supplemented with either 50µg/mL of ampicillin or 25µg of Kanamycin and 
incubated at 370C shaking at 250rpm for 6 hours. The starter culture was diluted 
further into 50mL of LB broth after 6 hours and incubated overnight for 16 hours 
at 370C shaking at 250rpm. The cells from overnight culture were harvested by 
centrifugation at 5000Xg for 10 minutes and the supernatant discarded. The 
plasmid DNA was isolated according to the Thermo Scientific GeneJET Plasmid 
Midiprep Kit #K0481, #K0482. 
In brief, the pellet was resuspended in lysis buffer to release the plasmid DNA, 
thereafter the lysate was neutralized to allow the denatured plasmid DNA to re-
anneal while other cell debris precipitate out of solution. The resulting precipitate 
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was pelleted by centrifugation with the supernatant containing plasmid DNA 
passed through the purification column where it binds to the silica membrane in 
the column due to its high salt concentration. The adsorbed DNA is washed to 
remove contaminants and eluted with the elution buffer.  
2.2.2 Plasmid quantification 
The eluted DNA was quantified to get the concentration and check for the quality 
of the plasmid DNA using Thermo Scientific Nano-Drop 1000 Spectrophotometer 
version 3.7.The concentrations were given in ng/μl of the plasmid concentration, 
and the A260/A280 ratio was checked for the purity of the plasmids ratio between 
1.7- 2 was acceptable as pure and any ratio above 2 is a sign of contamination 
with proteins. The measurements were done according to the Thermo Scientific 
Nano-Drop™ 1000 Spectrophotometer manual. 
2.3 Propagation of the EV71 virus 
The EV71 virus was produced in the rhabdomyosarcoma (RD) cells. RD cells 
were seeded in 75mm tissue culture flasks and after about 80-90% confluency, 
infected with EV71 virus at MOI of 0.1. The cells were monitored for the visible 
cytopathic effects (CPE) daily, and harvested when CPE appeared (usually at 
around 48h). The viral stocks were aliquoted in 1mL cryo tubes and stored frozen 
at -800C. 
2.3.1 Optimization of virus infection 
The UBL over-expression assay was performed in HEK293T cells, which met the 
twin condition of transfection friendliness and susceptibility to EV71 infection (or 
dengue virus, the other virus used in this study). To determine the right 
concentration of the virus that will give optimum infection during IFA 
experiments screen, we decided to use 0.5, 1, 2.5, 5, 7.5, 10 and 15μl of the virus. 
The HEK-293 T cells were seeded 24 hours prior to infection day, after 24 hours, 
the cells was infected at the above concentrations. 24 hours post-incubation, the 
cells were fixed and IFA was carried out as stated in the section below. The 
images were taken on a fluorescence light microscope and compared at different 
cell concentrations 6000cells/well and 8000cells/well in 384 well plates (Coaster). 
22 
 
We also optimized dengue virus (serotype 2, NGC strain) infection conditions, 
which was used in some cross-validation studies reported in this thesis. 
2.3.2 Optimization of plasmid expression 
To determine the right amount of the plasmid for the transfections, we used 
100ng, 200ng, 500ng and 1μg of the UBL plasmid for transfections in 96 well 
plates (Coaster).Plasmid carrying vector backbone only (pLX304) was used as the 
negative control for this optimization. The cells were reseeded at 
8000cells/well/30μl in 384 well plates after 24 hours and further incubated at 
370C overnight. After 24 hours the cells were infected with 10μl/15μl serum free 
medium of the EV71 virus. 
2.4 Screening of UBL library 
The screen was performed in 384 well plates, in triplicates. HEK293T cells were 
transfected (using the transfection reagent PEI) by 500ng of UBL plasmids (7 
plates of 96 plate well format) and incubated for 24hours. 24 hours post-
incubation, the cells expressing each of the UBLs were reseeded into 384 well 
plates in triplicates, incubated for 24 hours. The cells were infected with EV71 
Virus at 0.1 MOI and 12 hours post infection the inoculums was removed and 
replaced with fresh DMEM medium. Cells were fixed by adding 4% 
paraformaldehyde (PFA) in 1xPBS for 30 min at 15 h post-infection. The cells 
were washed 3 times using 1X PBS, then permeabialized for 30 minutes in 100X 
0.2% Triton, and blocked in 5% normal goat serum in 1xPBS for another 30 
minutes. The cells were washed 3 more times with 1X PBS and immunostained 
using the antibody mAb 53 detecting VP1 capsid protein of EV7172 and plates 
incubated overnight at 40C. 
The primary antibody was removed and the cells washed thrice with 1xPBS, 
followed by signal development using Alexa fluor 488 conjugated secondary 
antibody. After 2 hours incubation at 370C, the plates were washed 3 times in 
1xPBS and 5µg/µl DAPI (nuclear counter-stain) added, incubated for 15 minutes 
then kept at 40C for imaging. Dengue screen was done following the same 
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procedure as described for EV71, and dengue specific mouse monoclonal 
antibody 4G2 antibody was used for staining the plates. 
2.4.1 Imaging and analysis of IFA results 
 
Two images were captured for each well of the 384-well plate, using the Image-
Xpress high-content imaging system (Molecular Devices).Viruses were imaged 
using green channel, and nuclei were captured using blue channel. Subsequently, 
the images were analyzed using the software MetaXpress (Molecular Devices) to 
determine the percentage infected cells. The analysis results were expressed as the 
percentage of infected cells.  
To ascertain accuracy, the images were also scored manually by comparing 
visually the intensity change between the plasmid carrying vector backbone only 
controls (pLX304), and the wells containing UBLs. The two site images per well 
were considered, for each of the triplicate for every UBL before scoring the 
images. The scoring was based on the fluorescence intensity changes, resultant 
threshold reduction or increase and resultant hits graded as either enhancing or 
limiting infection. The scoring took into effect all the three copies, and the two 
site images per well. The hits were selected by determining the Z-score, based on 
the mean of the values. The formula used for Z-score determination: z=x- μ / σ, 
where x is the average infection for the two sites, σ is the standard deviation of 
the population, μ is the plate mean.  Any UBL that caused a reduction cell number 
more than 50% was eliminated as toxic. 
2.5 Western blot analysis of UBL hits against SCARB2 receptor 
2.5.1 Making of 12.5% SDS gel 
Stacking and resolving gels were prepared according to the order in the table 3 
below, adjusting the volumes depending on the number of gels made. Ammonium 
Per-sulfate and TEMED were added right before pouring each of the solutions 
(TEMED catalyzes formation of free radicals, leading to APS forming O2 free 
radicals resulting to the polymerization of acrylamide/bis-acrylamide forming gel 
matrix for separating the proteins by size). The separating gel solution was added 
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to the casting chamber between the glass plates up to approximately 0.7cm below 
the comb when comb is in place. A small layer of isopropanol was added to top of 
the gel prior to polymerization to straighten the level of the gel immediately after 
adding the resolving gels. Once the resolving gel has polymerized, isopropanol 
was removed, the top of the gel rinsed with distilled water and dried off 
completely. The stacking gel was quickly added using 1mL pipette to the casting 
chamber between the glass plates till the space was full and immediately inserted 
appropriate comb (15well or 10well). The top portion was allowed to dry, before 
removing the combs, for future use, the gels were wrapped with paper towel 
soaked in water then wrapped with aluminium foil and stored at 40C. 
 
Table 3 Recipe for 12.5% stacking and resolving gels (1 gel) 
 
Stacking gel 2mL Separating gel 5mL 
Distilled de-ionized water 1.36 1.65 
30% acrylamide/Bis 37.5.1 0.34 2 
1 M Tris-HCL, pH 6.8 0.25 - 
1.5 M Tris-HCL, pH 8.8 - 1.25 
10% SDS 0.02 0.05 
10% Ammonium Persulfate 0.02 0.05 
TEMED 0.002 0.005 
The gels were made in the order in the table, with APS, and TEMED added just before 
pouring the gels to the glass plates. The formulation was adopted from the Bio-Rad 
protocols bulletin 620 73. 
2.5.2 Preparation of 5X loading dye 
250 mM Tris-HCl pH6.8, 10% SDS, 30% Glycerol, and 5% β-mercapitalethanol, 
0.02% bromophenol blue were used to prepare 5X SDS loading. 
2.5.3 Receptor expression optimization 
To determine the concentration of the SCARB2 receptor for the Western blot 
analysis, we over-expressed the plasmids at different concentrations: 100ng, 
200ng, 500ng and 1μg. The HEK293T cells were plated in 24 well plates 
(Corning) at 0.3 X106 cells per well and incubated for 16 hours at 370C, 5% CO2 
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in a CO2 incubator. After 16 hours the transfections mix was set up for the two 
receptors at 200ng, 500ng and 1μg, and 3μl/μg of PEI added and volume topped 
up to 100μl with serum free medium. The master mix was mixed by short 
vortexing followed by a quick spin and incubated for 30 minutes. The master mix 
was added to the respective wells and incubated further for 42hours at 370C 
incubator (the medium was changed after 24 hours to prevent cell death).The 
samples were harvested in ice cold 1xPBS42 hours post-incubation, re-suspended 
in lysis buffer supplemented with 1X protease inhibitor cocktail (Thermo 
Scientific). The samples were run on the 4-20% Bio-Rad precast gels (1X running 
buffer: 25 mM Tris, 192 mM glycine, 0.1% SDS), at 100Volts for 1hour 
thereafter transferred to the polyvinylidene difluoride(PVDF) membrane using 
cold 1X transfer buffer (25 mM Tris, 192 mM glycine, 10% methanol). The blot 
was blocked in 5% dry skimmed milk for one hour at 250C, washed in 1X TBST 
and incubated in primary antibody with dilution of 1:200 ( Santa Cruz ; Mouse 
LIMP II for SCARB2, PSGL1 for SELPLG) overnight at 40C. The membranes 
were washed 3 times; anti-mouse monoclonal Oddsey 680 secondary antibody 
was used for blotting at 1:5000 dilutions in 5% dry milk in TBST and incubated 
for 1hour at 250C. The blots were developed by LI-COR Odyssey 2012. 
2.6 Western blot analysis 
The HEK293T cells were seeded in 24 well plates at 0.3x106 cells per well and 
incubated overnight for 16 hours at 370C incubator, 37% CO2. At 16 hours, the 
transfection mixture was made by adding 1µg of UBLs, 1µg of SCARB2 plasmid, 
PEI was added at 3µl/µg of the total DNA, and the volume topped up with serum 
free medium to 100µl. The master mix was mixed by short vortexing followed by 
a quick spin and incubated for 30 minutes and thereafter added to the respective 
wells followed by incubation for 42hours at 370C incubator (the medium was 
changed after 24 hours to prevent cell death). 
At 42 hours post transfections, the cells were harvested in ice cold 1xPBS and re-
suspended in lysis buffer (20mM Tris-HCl, pH 7.6, 120mM NaCl, 2mM EDTA, 
1% Triton X-100, 10% glycerol) supplemented with 1X protease and phosphatase 
inhibitor cocktail (Thermo Scientific). The cell lysate were incubated at 40C 
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tumbling for 50 minutes and clarified by centrifugation at 14,00X g for 
10minutes. The protein concentration of the cell lysates was measured by 
Bradford method as described earlier74. Cell lysate containing 30 µg of proteins 
was mixed with loading dye (5X loading dye) and loaded per well of a 12% SDS-
polyacrylamide gel and subjected to electrophoresis (100Volts for 1hour) in 1X 
Tris-glycine SDS-running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS).The 
resolved proteins were transferred onto immune-blot polyvinylidene difluoride 
(BIO-RAD) membrane at 40C in 1X transfer buffer at 80V for 1 hour. The 
membranes containing-proteins were blocked in 5% dry milk in 1XTBST (50mM 
Tris-HCL (pH 7.4), 150mM NaCl, and 0.1% Tween 20). The membrane was 
incubated with LIMPII-Santa Cruz primary antibody (1:200 in 5% dry milk in 
TBST), or V5 antibody (Santa Cruz) primary antibodies overnight at 40C. The 
membrane was washed 3 times in 1XTBST each for 3minutes before further 
incubation with IRD Fluor 800-labeled IgG (1:500 dilution in 5% dry milk) or 
IRD Fluor 680-labeled IgG secondary antibody (1:500, in dry milk) for 1 hour. 
One hour post-incubation with secondary antibody, the membranes were washed 
5 times with 1XTBST and exposed to 700 to 800 nm wavelength on the Odyssey 
Infrared Imaging System (LI-COR). The images were analyzed by the Odyssey 
software. The molecular sizes of the developed proteins were determined by 
comparison with pre-stained protein markers (Fermentas, Maryland, CA).The 
membranes were stripped for 30 minutes and thereafter probed for anti-GAPDH 
as internal control. 
2.7 statistical analysis 
The scoring was based on the fluorescence intensity changes, resultant threshold 
reduction or increase and resultant hits graded as either enhancing or limiting 
infection. The scoring took into effect all the three copies, and the two site images 
per well. The hits were selected by determining the Z-score, based on the mean of 
the values. The formula used for Z-score determination: z=x- μ / σ, where x is the 
average infection for the two sites, σ is the standard deviation of the population, μ 
is the plate mean.  Any UBL that caused a reduction cell number more than 50% 
was eliminated as toxic. Given that HEK293T cells used in the study clamp 
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together, we did use the statistical analysis to validate the manual scores and not 
as primary reference point. We did use the manual score for the initial hit 
selection and the Z-score based statistics to compare the hits at the later stage. The 
























3.1 EV71 infection assay development 
HEK293T cells were selected for the UBL over-expression screen assay for three 
reasons: (a) EV71 can infect it very well; (b) it can be easily transfected with 
plasmids. Because our assay involves UBL plasmid transfection, this study 
needed a cell line that could be easily transfected; and (c) it has well characterized 
intact innate antiviral immune system. To determine the virus concentration and 
number of cells required for reasonable infection, we did an optimization by 
seeding 6X103 and 8X103 cells per well, incubating the cells for 24 hours at 370C. 
The cells were infected with different amount of EV71 virus; 0.5μl, 1μl, 2.5μL, 
5μl, 7.5μl, 10μl, and 15μl. The cells were incubated for 24 hours, fixed and IFA as 
in methods above. Our results showed that using 8000cells/well and infection 
with 5μl of the EV71stock virus (translating to 0.1 MOI) for 24 h gave a robust 
infection of around 10%, and thus was chosen for further screen. 
3.2 Optimization of over-expression screen 
Taking into account the amount of plasmid needed for robust protein expression, 
and possible effect of transfection reagent PEI on EV71 infection, we decided to 
use 8X103cells/well as discussed in 3.1 and transfect the cells with 500ng of 
plasmid. The backbone only empty vector was used as a negative control. PEI and 
two known UBLs were used as controls. The cells were incubated in humidified 
incubator at 370C for 24 hours after transfection; the cells were washed with pre-
warmed 1xPBS and reseeded in 384 well plates. The cells were then incubated for 
24hours thereafter infected with EV71 virus at 0.1MOI, and incubated further for 




3.3 UBL over-expression Screening identifies novel pro-viral and antiviral 
UBLs 
We next performed an over-expression screen with 562 UBLs, to determine their 
effect on EV71 infection. HEK293T cells transfected with UBLs were infected 
with EV71 virus at 0.1MOI for 24 hours before processing the cells for IFA. After 
IFA, images were captured by fluorescent microscopy, and data were processed to 
determine the effect of UBLs on EV71 infection. From the Z-scores data analysis, 
any UBL who’s over expression caused a change in infection +2 standard 
Figure 6 EV71 virus Optimization 




deviations above the plate mean were grouped as potential pro-viral ubiquitin 
ligases and adaptors. 54 of the UBLs (Table 5) from the screen showed an 
increased viral infection phenotype indicating a possible role in promoting EV71 
virus by either promoting the viral attachment, entry into the cells, replication or 
even egress. The Z-score cut-off of -2 standard deviations below the plate mean 
was grouped as potential anti-viral ubiquitin ligases and adaptor. Figure 7 shows 
the scatter plots for the Z-scores from Dengue and EV71 screen. There were 65 
UBLs/adaptors (Table 5) that showed reduced phenotype in EV71 viral infection 
of the HEK293T cells. It is important to note that as earlier mentioned in methods, 
the Z-score statistics was not the primary reference point and was only used to 
compare the hits as it cannot be wholly relied on due to the clamping of cells and 
thus inaccurate scores. 
 
 Figure 7 scatter plot of the Z-score for Dengue and EV71 screen 
The figure shows scatter plots representing the Z-score for the Dengue and EV71 hits 
from the statistical analysis. 
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3.4 Analysis of hit genes from UBL Over-Expression screening 
3.4.1 Anti-viral UBLs 
Following the analysis of the IFA results, 65 UBLs were found to reduce EV71 
viral load. Out of the 64 genes, 7 TRIM family, 10 RNF family, 2 MARCH 
family, 3 KLHL family UBLs were the major UBL families that showed anti-viral 
activity. TRIM39 which is closely related to TRIM38 (TRIM39 and TRIM38 
share 38% amino acid identity) which had been shown to promote K63-and K48-
linked ubiqutination of cellular proteins24,75 thus may be playing important role in 
the marking of viral fused receptors for proteasome degradation.MARCH11 is a 
protein coding gene which possesses E3 ubiquitin ligase activity that targets CD4 
for ubiquitination, and adds Ubiquitin to target lysine in substrate proteins thereby 




The E3 ubiquitin-protein ligase RNF proteins such as; RNF10, RNF135, RNF152, 
RNF167, RNF180, RNF4, RNF122, RNF168, RNF19A also had inhibitory effect 
on EV71 infection.  
 
3.4.2 Pro-viral/ infection enhancers 
Four images per well of the 384 well plates were taken, analyzed and compared 
with the control wells. The Z-score was calculated and an average value 
compared to average value of the controls (HEK293T cells with only EV71 virus 
without UBL) as supplement to the manual scoring given that the automated 
scoring would have not been accurate given that the HEK293T cells clamp 
together thus may give false positive or negative values as the analysis depends 
on counting the cell nuclei. Comparing the visual scoring and the automated, 
grouped the hits as either enhancers or inhibitors. Figure 8 gives an overview of 
the images taken during the screen for the pro-viral UBLs in EV71 infection 
showing a higher signal compared to the control wells. 54 UBLs from the screen 
Figure 8 Representative images of newly identified Antiviral UBLs 
The top panel shows infection profile scoring: control (pLX304 carrying vector backbone only), RNF32, 
KCNS3, and KBTBD8 respectively from left to right with the corresponding DAPI screen shots shown 
below each FITC image. 
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library showed increased EV71 viral load from the IFA data analysis. Out of the 
54 proviral UBLs, 14 were TRIM family, 8 RNF, 1 MARCH, 4 F-box gene, 2 
kelch-like families, with the full UBL list shown in table 4.  These were seen to 




Table 4 Pro-viral and anti-viral UBLS and adaptors EV71 viral load 
The UBLs/adaptors which are either inhibitory or enhancing phenotype as colour coded  
UBL UBL UBL UBL 
TRIM 15 ZBTB46 TRIM13 KBTBD3 
TRIM 20 FBX33 TRIM28 KBTBD8 
TRIM 25 FBXL16 TRIM39 UBE3B 
TRIM 40 FBXL6 TRIM50 ZNRF2 
TRIM 41 FBXO36 TRIM56 ZNRF3 
TRIM 9 UBE4B TRIM63 ASB4 
TRIM-16 ANAPC11 TRIM33 BTBD1 
TRIM-23 ASB15 RNF10 FANCL 
TRIM24 BTBD14B RNF135 HERC4 
TRIM-32 BTBD3 RNF152 ITCH 
Figure 9 Representative images of newly identified Pro-viral UBL 
The top panel shows infection profile scoring: control (pLX304 carrying vector backbone only), TRIM32, 
RNF142, FBX33 respectively from left to right with the corresponding DAPI screen shots shown below each 
FITC image.  
35 
 
TRIM40 CPSF1 RNF167 KCNS3 
TRIM45 DCST1 RNF180 KEAP1 
TRIM-6 DPF1 RNF4 KIAA0317 
TRIM-61 G2E3 RNF122 LGALS3BP 
RNF113B GAN RNF168 MDM4 
RNF114 GZF1 RNF19A MID1 
RNF142 HACE1 RNF32 OSTM1 
RNF157 KCTD20 MARCH8 PCGF1 
RNF165 MIB1 MARCH11 PCGF6 
RNF172 PEX12 BTBD1 PHF7 
RNF200 RFWD2 KLHL12 PPIL2 
RNF35 SPOP KLHL21 PXMP3 
MARCH9 SPOPL KLHL9 RCBTB1 
BTBD14B UNK ZBTB16 SH3RF2 
BTBD3 WDSUB1 ZBTB3 SHKBP1 
KLHL11 WHSC1 ZBTB24 SOCS1 
KLHL31 WSB1 ZBTB7C SPRYD5 
FBXO9 UHRF1 FBXL4 STUB1 
KBTBD2 VPS41 FBXO24 TRIP12 
  ZFAND5 FBXO38 TTC3 
  Anti-viral UBLs  





3.5 Effect of pro- and antiviral UBL hits on SCARB2 receptor stability 
 
We subsequently aimed to discover novel principles underlying the regulation of 
EV71 viral infection by the newly identified UBLs that were found to alter the 
infectivity of EV71. Given that receptors constitute the key early determinant of 
susceptibility to viral infections, we hypothesized that some of the identified 
UBLs may impact on viral infection through the regulation of receptor 
functioning or availability. Despite their key role in viral infection, a systematic 
investigation on the regulation of viral receptors in the context of infection across 
multiple viruses is yet to be performed. We therefore explored this paradigm 
using the 119 hit UBLs and SCARB2, the known EV71 receptor identified earlier 
in 20087.We hypothesized that some of the newly identified UBLs in this study 
might be regulating EV71 infection, by affecting the stability of SCARB2. To test 
our hypothesis, HEK293T cells were transfected with 1μg of plasmid expressing 
SCARB2, with each one of the hit UBLs found to alter the EV71 infection. 42 
hours post-transfection the protein samples were analyzed by Western blot. As 
given in Table 6, 10 UBLs out of 119 tested showed possible degradation of 
SCARB2 receptor forming 9.2% of the anti-viral UBL hits with the remaining 
90.8% having no effect on the expression of the SCARB2 receptor pointing out 
that they be playing anti-viral role at different stages of EV71 infection. 
We first determined the optimal amount of SCARB2 to be used for co-
transfection with the 119 UBL hits and SCARB2 receptor. HEK 293T cells were 
transfected with 100ng, 250ng, 500ng, and 1μg of SCARB2 plasmid in a 24 well 
culture plates, then harvested the cells for Western blot after 42 hours. On the 

















3.5.1 Optimization of SCARB2 degradation assay 
After the optimization for the SCARB2 expression levels, we determined the 
effect of UBLs on SCARB2 levels by UBL over expression. HEK293T cells were 
seeded, incubated for 24 hours after which transfected with 1μg of SCARB2 
plasmid and 1μg of UBL hit genes, incubated the cells for 42 hours at 370C 
humidified incubator, with 5% CO2.  The cells were processed for Western blot as 
described in the methods section. The blots were probed using SCARB2 mouse 
monoclonal IgG2bantibody (Santa Cruz Biotechnology), and the blots developed 
using Odyssey Goat anti-mouse IRDye 680RD (LI-COR). 
 
Figure 10 Expression levels of human SCARB2 in HEK293T cells 
Left lane is molecular weight markers. Lanes 1-4 represents expressions of 100ng, 






Figure 11 Western blots representing 48 Over-expressed UBLs on stability of SCARB2 
PCGF6, RNF135, LGALS3BP, TRIM39, KTBTBD8, PPIL2, KEAP1, TRIM28, TRIM33 reduced SCARB2 
band intensity compared to the plasmid carrying vector backbone only (EV) 
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3.5.2 Several UBLs mediate degradation of cellular receptor of EV71 virus 
 
The results shown in figures 10 and 11identified 10UBLs who’s over expression 
strongly promoted degradation of co-transfected SCARB2 receptor. The observed 
difference in the band intensity was confirmed by doing densitometry and the 
graphs shown in supplementary figure 1. Out of these 10UBLs, 3 were from the 
TRIM family (TRIM33, TRIM39 and TRIM28), 2 MARCH family proteins 
(MARCH8, MARCH11), 1 RING finger protein (RNF135), 1 kelch-like family 
(KLHL21), 1 polycomb group (PCGF6), 1 kelch repeat and BTB containing 
domain (KBTBD8) and one lectin-galactoside  binding protein(LGALS3BP). The 
Figure 12 Western blots representing 32 UBLs against over-expressed SCARB2 
MARCH11 and KLHL21 showed degradation of SCARB2, compared to the empty vector (EV) controls  
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UBLs that enhanced EV71 infection appeared not to have any effect on SCARB2 
from our results, pointing out that may be using unidentified mechanism to 
support EV71 infection. Some TRIM family proteins (TRIM56, TRIM13, TRIM 
50 and TRIM 63) with anti-viral effect in the cell based EV71 infection assay 
showed no significant effect on the SCARB2 receptor. The membrane-associated 
ring finger (MARCH) family also showed antiviral effects on the EV71 infection; 
MARCH8, and MARCH11, which showed degradation of the SCARB2 receptor 
also had an effect in the EV71 infection. To validate the observed degradation of 
SCARB2 by 10UBL hits, we performed a confirmatory experiment by repeating 
the primary degradation assay. As shown in figure 12, repeat assay also showed 
that the observed SCRAB2 degrading UBL hits KBTBD3, LGALS3BP, TRIM 39, 
KLHL21, MARCH11, PCGF6, and TRIM33consistently reproduced their ability to 




Figure 13 Confirmatory analyses of UBLs degrading SCARB2 
The resultant hits from the first screen of the UBLs effect on SCARB2 receptor were 
retested and from this figure, UBE3B, ZFAND5, and PPIL2 showed no convincing 
degradation, compared to PCGF6, RNF135, LGALS3BP, TRIM39, KTBTBD8, 
KLHL21,TRIM33, TRIM28, MARCH8, and MARCH11 which showed same effect on  




Table 5 Antiviral UBLs degrading SCARB2 
UBL EFFECT ON EV71 
INFECTION 
EFFECT ON SCARB2 
KBTBD8 reduces degrades 
KLHL21 reduces degrades 
LGALS3BP reduces degrades 
MARCH11 reduces degrades 
MARCH8 reduces degrades 
PCGF6 reduces degrades 
RNF135 reduces degrades 
TRIM28 reduces degrades 
TRIM33 reduces degrades 
TRIM39 reduces degrades 
The table shows those UBLs who’s over expression reduced EV71 viral load and also 
promoted degradation of SCARB2 receptor. Reduces, reduces EV71 viral load, degrades, 
promotes degradation of SCARB2 receptor. 
3.5.3 UBL-mediated degradation of SCARB2 receptor is dose dependent 
 
We further determined the dose response effect of UBL on SCARB2 degradation. 
For this, we used 3 different UBL concentrations - 1μg, 500ng and 250ng, while 
keeping constant the concentration of SCARB2 plasmid. From our results, we 
observed increasing SCARB2 band intensity as the UBL concentration reduces, 
indicating that SCARB2 degradation is dose dependent. LGALS3BB, KLHL21, 
and MARCH8 showed strong effects on the SCARB2 receptor even at 250ng. 
PCGF6, RNF135, TRIM33 and KBTBD8 showed dose dependent but moderate 
degradation of SCARB2. From this data, it was reasoned that several antiviral 









3.6 Cross viral effects of UBL hits 
To find out whether the UBL hits were specific to EV71 virus or may playing a 
role in many other RNA viruses, we tested all the identified 119 UBL hits also 
against the infection of dengue virus. Out of these 119 UBL hits from EV71 
screen, 55 showed between >50% reduction/increase in the dengue virus infection 
intensity. Out of the 54 pro-viral UBLs in the EV71 screen, ZSWIM2, UBOX5, 
TRIM9 and ASB8 also showed a high viral load in during the dengue virus 
infection. On the other hand, DTX3L, TRAF4, RNF5 which showed increased 
viral load for EV71 infection showed reduced viral load for dengue virus 
infection. Majority of the antiviral UBLs for EV71 showed reduced viral load for 
dengue virus too, with the exception of VPS41, SYVN1, HECTD3, which 
showed increased viral load for dengue viral infection in the HEK293T cell based 
assay. From the 10 antiviral UBLs that degraded SCARB2 receptor, only 
Figure 14 SCARB2 degradation is dose dependent 
KBTBBD8, KLHL21, MARCH11, LGALS3BP, MARCH8, PCGF6, RNF135 
and TRIM33 were transfected together with 1ug of SCARB2 receptor at the 
indicated concentrations, the blot probed with LIMPII antibody for the SCARB2. 




LGALS3BP, PCFG6, and TRIM 39 showed remarkable reduction in dengue virus 
load. 
 
Table 6 EV71 hits and Dengue virus hits 
SYMBOL  EFFECT ON 
EV71INFECTION 
 EFFECT ON 
DENGUE 
INFECTION 
SYMBOL  EFFECT ON 
EV71INFECTION 
 EFFECT ON 
DENGUE 
INFECTION 
ZSWIM2 H H RAPSN L L 
ZFAND5 L L PXMP3 L L 
ZFAND3 L L PHF7 L L 
ZBTB16 L L PCGF6 L L 
ZBTB1 L L PCGF1 L L 
VPS41 L H MID1 L L 
UBOX5 H H MDM4 L L 
UBE3B L L LRSAM1 L L 
TRIM9 H H LONRF1 L L 
TRIM56 L H LGALS3BP L L 
TRIM39 L L KLHL12 L L 
TRIM36 L L KCTD3 L L 
TRIM13 L L KCTD14 L L 
TRAF4 H L KCNS3 L L 
SYVN1 L H KCND3 L L 
STUB1 L L KBTBD3 L L 
SH3RF2 L L KBTBD2 L L 
RNF8 L L HECTD3 L H 
RNF5 H L FBXW7 L L 
RNF32 L L FBXO5 L L 
RNF180 L L FBXO27 L L 
RNF148 L L FBXO25 L L 
RNF146 L L FBXL13 L L 
RNF138 L L ENC1 L L 
RNF10 L L DTX3L H L 
RCBTB1 L L ASB8 H H 
RBX1 L L ASB4 L L 
      ARMC5 L L 
 
The table shows the screen results for Dengue virus infection profile compared with the 
initial screen of the EV71. 119 EV71 hits both inhibitory and enhancing UBLs were 
tested against Dengue virus, and dengue the viral load determined by IFA. L: Lower viral 




Table 7Annotated functions of UBL affecting EV71infection 
The reported function of the 11 UBLs that we proposed EV71 virus by targeting the 
SCARB2 receptors. The data was mined using STRING 9.1, and all the reported 
interactions noted, this was confirmed by the individual papers that reported the 
interaction and proposed functions from GO analysis, and reference of functions by 
similarity of the protein sequences. 
3.7 protein-protein interactions, gene ontology of the UBL hits 
We subsequently performed bioinformatics analysis of the identified hit UBLs, to 
see if they represent any known signaling network. For this, we performed 
UBL ANNOTED/PREDICTED FUNCTION References 
KBTBD8 Located in the Golgi apparatus and translocates 
to the spindle apparatus during mitosis 
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KLHL21 Targets aurora B to mid zone microtubules in 
anaphase, required for cytokinesis. 
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LGALS3BP Promotes intergrin-mediated cell adhesion. 
Plays a role in natural killer cells, and 
lymphokine activated killer cell cytotoxicity; 
May stimulate host defense against viruses and 






MARCH11 Is implicated in ubiquitin-dependent protein 
sorting in developing spermatids, 
76
 
MARCH8 Induces internalization of membrane 
glycoproteins, mediates ubiquitination of CD86 
and MHC class II proteins: HLA-DR alpha and 
beta, may also promote ubiquitination and 
endocytosis of transferring receptor 
82,83,84,85
 
PCGF6 Transcription repressor, may modulate levels of 





RNF135 Plays a role in innate immune defense against 
viruses, ubiquitinates RIG-I  to promote 




TRIM28 Interacts with TRIM24,TRIM33 to promote  
hepato-cellular carcinoma in mouse 
89
 
TRIM33 Acts as an E3 ubiquitin-protein ligase ,Promotes 
hepatocellular carcinoma in mouse, inhibits 
transcriptional  response to transforming growth 
factor beta, control of cell proliferation, is 
targeted by Adenovirus  E4orf6 for degradation 
90,91,89
  
TRIM39 May facilitate apoptosis by inhibiting APC/A-
Adh1 mediated poly-ubiquitination and 
subsequent proteasome-mediated degradation of 





protein-protein interactions using the STRING biological database and web 
resource software version 9.1 (Search Tool for the Retrieval of Interacting 
Genes/Proteins). This was carried out by doing a multiple search of the 10 UBL 
hits that showed both reduced viral load on EV71 screen, and Dengue screen and 
showed degradation of the SCARB2 receptor. The score was set at medium 
confidence score of 0.4, with neighborhood, gene fusion, co-occurrence, co-
expression experiments, databases and text mining set as active prediction 
methods. The Protein-protein interaction network as visualized by STRING is 
represented in the screen shot shown in figure 14 and 15. 
Analyzing the interaction of 10UBL hits, there were no reported or predicted 
interactions between the proteins, with only interactions between TRIM33, 
TRIM28 and STUB1 when the limit is set as low, as high limit showed no 
interactions.  To query for some of the hits TRIM33, RNF135, MARCH11 and 
LGALS3BP to find out the reported signaling interactions, we found a good 











Figure 15 Screen shot of interactions between different UBL hits 
From this search on STRING software version 9.1, there is no reported association between 8 out of the 11 
proteins used in the search, with TRIM33, TRIM28, and STUB1having annotated interaction (top panel left). 
Top panel right: Interaction between Trim33 and other immune modulators such as SMAD proteins. Bottom 













This study identified several novel pro-viral and antiviral UBLs affecting EV71 
infection process. Among these, a small subset promoted degradation of EV71 
receptor SCARB2. Further studies revealed that a large number of the UBLs 
affecting EV71 infection also altered dengue virus infection, with comparable 
effects. However, several EV71 hit UBLs did not affect dengue virus infection. A 














The discovery of host factors involved in EV71 infection is a very promising 
approach to develop effective control measures against pathogenic RNA viruses. 
The current study systematically investigated a number of commercially available 
human ubiquitin ligases for potential antiviral effect against the infection of EV71 
virus. Our efforts have identified a set of known UBLs that inhibit or promote 
EV71 infection in HEK293T cells. Furthermore, we determined that the newly 
identified UBLs included those that have been associated with different viral 
infections, targeting the entry and post-entry steps of viral infection. 
Ubiquitination has been implicated in regulation of several cellular processes such 
as protein turnover, DNA repair, cell cycle regulation, cell death, endocytosis, 
autophagy, initiation and regulation of innate and adaptive immune responses38. 
The pioneer a study on the ubiquitin-mediated protein degradation was rewarded 
in 2004 with Nobel Prize in chemistry94,55. Ubiquitin conjugating system plays 
multiple roles in viral replication and infection process. Viruses being 
intracellular parasites, they rely mostly on many conserved host cell machineries 
for their own replication. Understanding the viral-host interaction is continuing to 
provide vital information towards unraveling the underlying molecular 
mechanisms of various emerging infectious diseases. Screening the human 
ubiquitin ligases library against different RNA viruses, gives a broad overview of 
the role of this important process in viral-human host cell interaction. 
RNA viruses has been shown to employ regulatory mechanisms for degrading 
excess viral proteins for efficient viral replication and this points to the possible 
role the human ubiquitin ligases that showed increased EV71 viral load. This 
speculation needs further studies in a proved system for analyzing viral-host 
proteins interactions.  The ubiquitin proteasome system thus forms a vital part of 
regulating viral protein functions without interfering with protein stability. The 
ubiquitin proteasome system mediated degradation may be playing an important 
role in regulating the EV71 RNA-dependent RNA polymerase (RdRps) and this 
need to be studied further. This has been shown to be effective in Sindbis virus, 
hepatitis C virus for efficient establishment of infection71. 
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In this study we report the role of ubiquitination in the cellular infection of EV71 
by interrogating the effect of over-expression of over 90% of known human 
ubiquitin ligases. Furthermore, we determined whether any of the ubiquitination-
related genes impacting on EV71 infection also affect SCARB2 receptor. We 
identified Although some studies have been carried out on the viral-host 
interaction with certain individual ubiquitin ligases, not much has been done at 
the genome level, here we demonstrate that by doing a genome wide screen of the 
human genome encoded UBLs, against EV71 and other RNA viruses, gives a 
broad view of the important roles the process of ubiquitination holds in 
establishment of a viral infection. This supports the notion that the ubiqutination 
can either be used by the viruses for their own benefit to establish an infection or 
against them in initiating and amplifying innate immune signaling against the 
viruses. 
Ectopic expression of the UBLs in HEK293T cells resulted in approximately 50-
90% reduction or increment in EV71 infection. One of the UBL hits of interest 
from our study and other studies is LGALS3BP which has been shown to be an 
interferon stimulated gene up regulated in serum of cancer and HIV patients 
pointing at the possible anti-viral or anti-cancer activity. LGALS3BP was further 
linked to decrease in the infectivity of the progeny of HIV-1 in a dose dependent 
manner 79 and the lower infectivity correlated with reduced virion incorporation 
of mature envelope glyco-proteins gp120 and gp41. From these studies, it is clear 
that this particular lectin galactoside binding soluble 3 binding protein may be 
playing an important in stimulating host defense against viruses and tumor. This 
is further supported by its ability to degrade SCARB2 receptor for EV71 pointing 
to the fact that it may be playing a role in the inhibition of the infection at early 
stages of pathogenesis. 
TRIM family proteins have been associated with modulation of innate immunity 
at different levels in signaling pathways. Further studies showed that nearly half 
of the TRIM proteins positively regulate the innate immune system95,60. This 
positive regulation of immune system may point to the fact that some TRIM 
proteins have been reported to be inhibiting Hepatitis B virus core promoter63 
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among other viruses. From our study, TRIM33, TRIM28 and TRIM39 inhibited 
EV71 pathogenesis as shown by the reduced viral load from IFA results. Further 
studies showed that the three TRIM proteins showed remarkable degradation of 
the co-transfected SCARB2 receptor. To this end, we need to further find out the 
possible stages at which these proteins block EV71 infection during the early 
stages. With many studies linking the TRIMs to biologically functional antiviral 
cytokine production in a E3-ligase dependent mechanism, and the role in NF-kB 
regulation96. These earlier studies on the possible roles of TRIM family proteins 
as immune enhancer, may point out their perceived roles in regulating EV71 
infection and to another extent Dengue virus infection from our model. 
When we tested the anti-viral UBLs on dengue virus infection, they showed 
consistent effect of lowered viral load. The table7 shows the summary of the 
effect of these UBLs on Dengue virus infection in HEK293T cells system. Many 
manuscripts have linked many UBLs to lysosomal degradation of the signaling 
components resulting to negative regulators of the TLR/NF-kB pathway97. This 
may partly explain the increased viral load in both EV71 and Dengue virus 
infections by TRIM9, ZSWIM2, UBOX5, and ASB8 which had enhancing effects 
for the two viruses we screened. This process of viruses taking advantage of the 
host mechanisms and proteins to establish efficient infection by stabilizing and 
degrading some of the viral encoded proteins have been reported for many 
viruses. We need to further design better study protocols to find out more on this 
aspect of both EV71 and Dengue infections. 
Some of the UBLs that showed reduced viral load from our screen data has been 
associated with negative regulation of immune cells activity, for example STUB1 
had been found to interact with Foxp3 promoting its K48 poly-ubiquitination in 
an HSP70 manner thus negatively regulating the regulatory T cells suppressive 
activity98. STUB1 has also been linked to T cell activation and may be playing a 
role in T cell immunity during EV71 infection and this needs further 
elucidation99.  
One interesting UBL was LGALS3BP a member of the galectins family of beta-
galactoside-binding proteins which have been implicated to be modulating cell-
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cell and cell-matrix interactions and had inhibitory effects to broad range of RNA 
viruses screened in our laboratory (Unpublished). LGALS3BP has also been 
reported in earlier studies expressing 90K/LGALS3BP in HEK293T cells to down 
regulate the relative amounts of mature gp120/gp41 thus interfering with 
packaging of the viral progeny into virions79 with its induction showing increased 
IFN-alpha in carcinoma cell lines all these pointing to its non-specific action 
against various viruses and may be in cancer. The interferon stimulation may 
point out to its possible role in regulation of the viral infection by interfering with 
the replication process of the virus which can be at entry point, fusion to improper 
viral protein synthesis and packaging. From our screening results, LGALS3BP 
showed reduced viral load thus inhibiting EV71 infection. Based on mechanistic 
studies, LGALS3BP showed possible degradation of SCARB2 receptor pointing 
to the fact that it may be acting at the initial stages of EV71 infection. Its specific 
role in a multiple of virus infection needs to be further validated as it has been 
reported in different studies. 
The role of ubiquitin proteasome system in degradation of viral proteins has been 
linked in many studies for efficient establishment of infection. Interferon 
stimulated gene 15 (ISG15) which is induced during viral infections, has been 
associated with prevention of ubiquitin mediated degradation of hepatitis C virus 
viral proteins facilitating its replication60. EV71 viral proteases have also been 
shown to interfere with the innate immune signaling pathways and their 
interaction with the newly described hits from our studies needs further 
validation.  
E3 ligases have been shown to regulate various viral and cellular processes such 
as virus budding, cell division, apoptosis, antigen presentation and innate 
immunity among other functions100. From our screen results, ZSWIM2 which has 
been linked to an increase in viral infection for dengue and EV71 infection has 
been linked to apoptotic pathway which thus may be playing a role in viral 
progeny release at the last stages of viral replication. This may explain the 
mechanism through which the pro-viral UBLs use to initiate successful entry, 
replication and egress from infected cells. The pro-viral UBLs may also be 
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targeting viral proteases required for cleavage of viral polyprotein and may trigger 
host cell apoptosis by activating pro-apoptotic mediators thus suppressing the host 
protein translation and transcription23,101. EV71 3C protease has been shown to 
undergo sumoylation at lysine 52 promoting its ubiquitylation and subsequent 
degradation71. 
To this end, majority of UBLs have been associated with the positive regulation 
of various innate immune signaling pathways such as RIG-I, TLRs, NLR and 
TNF signaling, all of which results in activation of NF-kB with eventual induction 
of interferon and pro-inflammatory cytokines24,38. The positive regulation of 
immune system signaling pathway points out to the possible inhibition of EV71 
infection as observed from our screening results. The 65 antiviral UBLs may be 
acting by enhancing immune signaling pathways involved in controlling viral 
infections. Out of the 65 antiviral UBLs, we have characterized 10 to be targeting 
the SCARB2 receptor for EV71in a dose dependent manner. 
 
We decided to find out the interaction among the 10 UBLs that inhibited EV71 
infection and also degraded SCARB2 receptor by using the STRING 9.1 
software. The observed interactions from bioinformatics analysis using STRING 
9.1 may be pointing at the complex network of interaction involved in the UBL 
activation of the innate immune system towards detecting of the virus infected 
cells and possibly subsequent activation of the adaptive immune response. Some 
of the components of the RNF135 include the SMAD protein family which has 
been associated with signaling transduction from transforming growth factor beta 
(TGF-β) to the nucleus for activation of downstream gene transcription102. From 
these interactions we speculate that the 10 UBLs may be functioning in 
conjunction with other proteins in order to inhibit EV71 virus infection, by 
affecting the SCARB2 receptor availability thus limiting the infection leading to 
low viral load observed. 
The specific roles of the pro-viral and anti-viral UBLs identified in this study 
need to be studied further, to find out the exact stage and mechanism they interact 
with both EV71 and dengue during infection. Future gene depletion studies will 
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further establish the role of the UBLs in viral infection. There have been possible 
roles related to some of these UBLs through gene ontology and inferring 
functions by relatedness and these need to be followed in the future studies. 
ZSWIM2 is an example that has been associated to activating apoptotic initiators 
and with proposed role of apoptosis in initiating viral egress, points to the possible 
role it may be playing in regulating efficient viral infection. The antiviral UBLs 
may be inhibiting the viral infections for the case of EV71 by interfering with the 
availability of the SCARB2 receptor, which has been associated with efficient 
attachment, un-coating of the EV71 virus particles.  
Our study presents a rich data at genome scale level that needs follow up studies 
to determine the mechanism and stage of EV71 infection they inhibit. Most 
studies have vital information on a section of UBLs especially TRIM proteins 
have been extensively studied62 with little attention to other families and this 
makes our screen unique. The methodology of the screen used in this study have 
been reported earlier and it has been proven to be efficient and accurate 
We therefore present the 10 antiviral UBLs for further studies, to find out the 
specific way they inhibit the EV71 infection establishment. This will open up 
more insight on the interaction between the virus and the host innate mechanisms 
important for initiation of anti-viral immune response towards RNA viruses. Our 
data points out the complex interactions between RNA viruses and the host 
proteins which may be playing an important role in directing the fate of viral 
infection. The role of ubiquitination is thus appreciated, and its role in promoting 
or inhibiting RNA virus infection of human host cells depends on specific 
interactions. Our findings provide an insight on the virus-host cell interaction in 
the context of UBLs and EV71 which is a reemerging human viral pathogen with 
a potential threat to the global health. We believe that our study forms a basis for 
future studies with an aim of determining mechanistic action of the final 10 
antiviral hits with a major goal of using the information towards vaccine and drug 






This study revealed a genome-wide picture of the importance and wider role of 
the Ubiquitination proteasome system (UPS) in regulation of viral infections, 
focusing on EV71. This study thus generate valuable information that will open 
up new directions for more studies on how we can actually mine this information 
toward the development of antiviral drugs and vaccine for the HFMD. 
 
From our study, we bring forward the following points from this work: 
 Our data demonstrate that the human ubiquitin ligases may either inhibit 
or enhance infection. 
 A subset of antiviral UBLs inhibitEV71 virus likely through regulation of 
the SCARB2 receptor functionality or availability thus inhibiting the 
successful entry and establishment of infection in host cells.  
  Each of these UBLs is likely to be acting at different stages of viral 
infection establishment; this can be at entry, translation, replication, 
assembly or egress stages. 
 Our data open up the field for follow up studies addressing the role of the 
different UBL families in regulating different RNA viruses, interactions 
with immune signaling pathways and may be immune disorders in future. 
Based on the unique nature of the different classes of UBLs in either 
promoting or inhibiting EV71 infection of human cells, future studies hold 
major promise to expose novel mechanisms and paradigms in virus regulation 
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Figure 17 supplementary figure 1: densitometry graphs 
The graphs show densitometry for samples 1-74 including the error bars. This is a 
representation of the densitometry results used for secondary analysis of the hits. The 
selected hits were retested to validate the results deduced from the initial analysis. 
